Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Escudero

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 5, 2002
Hyperuricemia, hypertension, and proteinuria associated with high-altitude polycythemiaJ Ashley Jefferson, Elizabeth Escudero, Maria-Elena Hurtado, et al.
Respiratory Physiology & Neurobiology|July 20, 2017
Acetazolamide and N-acetylcysteine in the treatment of chronic mountain sickness (Monge's disease)Shailendra Sharma, Jane Gralla, Joyce Gonzalez Ordonez, et al.
Kidney International Reports|May 2, 2022
Efficacy and Safety of Dapagliflozin in Patients With CKD Across Major Geographic RegionsPriya Vart, Ricardo Correa-Rotter, Fan Fan Hou, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 31, 2020
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristicsDavid C Wheeler, Bergur V Stefansson, Mikhail Batiushin, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 5, 2002
Hyperuricemia, hypertension, and proteinuria associated with high-altitude polycythemiaJ Ashley Jefferson, Elizabeth Escudero, Maria-Elena Hurtado, et al.
Respiratory Physiology & Neurobiology|July 20, 2017
Acetazolamide and N-acetylcysteine in the treatment of chronic mountain sickness (Monge's disease)Shailendra Sharma, Jane Gralla, Joyce Gonzalez Ordonez, et al.
Kidney International Reports|May 2, 2022
Efficacy and Safety of Dapagliflozin in Patients With CKD Across Major Geographic RegionsPriya Vart, Ricardo Correa-Rotter, Fan Fan Hou, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 31, 2020
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristicsDavid C Wheeler, Bergur V Stefansson, Mikhail Batiushin, et al.
Pageof 3